Skip to main content

Ischemic Heart Disease

15
Pipeline Programs
23
Companies
35
Clinical Trials
1 recruiting
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
2
3
0
1
6
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 40 programs with unclassified modality

On Market (1)

Approved therapies currently available

Astellas
LEXISCANApproved
regadenoson
Astellas
Adenosine Receptor Agonist [EPC]intravenous2008

Competitive Landscape

22 companies ranked by most advanced pipeline stage

Medtronic
MedtronicNJ - Phillipsburg
8 programs
1
1
StentPhase 4
Resolute Integrity™ Zotarolimus-Eluting Coronary Stent SystemPhase 31 trial
Drug eluting stent treatmentN/A1 trial
RESOLUTE China Registry:N/A1 trial
Resolute Integrity™ Zotarolimus-Eluting Coronary Stent SystemN/A1 trial
+3 more programs
Active Trials
NCT01132456Completed312Est. Apr 2016
NCT01243749Completed1,800Est. Dec 2017
NCT03118531Completed40Est. Apr 2023
+4 more trials
Astellas
AstellasChina - Shenyang
3 programs
1
1
RegadenosonPhase 41 trial
RegadenosonPhase 11 trial
Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress TestsN/A1 trial
Active Trials
NCT00907855Completed200
NCT00881218Completed50Est. Dec 2011
NCT01779869Completed16Est. Jun 2015
Pfizer
PfizerNEW YORK, NY
2 programs
2
EplerenonePhase 41 trial
celecoxibPhase 4Small Molecule1 trial
Active Trials
NCT00187889Completed70Est. Dec 2011
NCT00565500Completed24Est. Apr 2005
Medinol
MedinolIsrael - Tel Aviv
1 program
1
Catheterization, stent deploymentPhase 41 trial
Active Trials
NCT00840775Completed278Est. Jun 2011
Kite Pharma
Kite PharmaCA - El Segundo
2 programs
1
1
GS-6615Phase 2
GS-6615Phase 1
Helixmith
HelixmithKorea - Seoul
2 programs
1
1
Stage 1-Low dose VM202RYPhase 21 trial
VM202-0.5 mgPhase 1/21 trial
Active Trials
NCT01422772Completed9Est. Aug 2014
NCT03404024Withdrawn0Est. Aug 2019
Innovation Pharmaceuticals
1 program
1
Standard Western medicine treatment + Chaigui Longmu Ejiao PastePhase 21 trial
Active Trials
NCT07478328Not Yet Recruiting60Est. Dec 2028
Cook MyoSite
Cook MyoSitePA - Pittsburgh
1 program
1
AMDCPhase 1/21 trial
Active Trials
NCT01353690Terminated9Est. Jun 2014
Fortis Therapeutics
Fortis TherapeuticsCA - La Jolla
1 program
1
Passive Leg RaisingPhase 11 trial
Active Trials
NCT02292888Unknown50
Abbott
AbbottABBOTT PARK, IL
8 programs
ABSORB GT1 BVSN/A1 trial
Absorb BVSN/A1 trial
Angiographic Guided PCIN/A1 trial
ICD ImplantationN/A1 trial
MINI TREK RX 1.20 mm Coronary Dilatation CatheterN/A1 trial
+3 more programs
Active Trials
NCT03409731Completed135Est. Feb 2023
NCT02943616Withdrawn0Est. Jan 2021
NCT07422688Enrolling By Invitation3,000Est. Sep 2039
+5 more trials
Meril
MerilIndia - Vapi
1 program
BioMimeTM Stent, Ultimaster® StentN/A1 trial
Active Trials
NCT02986295Unknown2,000Est. Jan 2021
Terumo Medical
Terumo MedicalGermany - Leverkusen
1 program
BioMimeTM Stent, Ultimaster® StentN/A
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Laboratory Biomarker AnalysisN/A1 trial
Active Trials
NCT03064360Completed200Est. Jan 2020
Precision BioSciences
1 program
Laboratory Biomarker AnalysisN/A
InspireMD
InspireMDIsrael - Tel Aviv
1 program
MGuard Coronary Stent systemN/A1 trial
Active Trials
NCT00922337Completed86Est. Dec 2013
Biotronik
BiotronikGermany - Berlin
1 program
Orsiro Sirolimus Eluting Coronary Stent SystemN/A1 trial
Active Trials
NCT03600961Terminated173Est. Dec 2021
Jubilant Therapeutics
1 program
Rb-82 RadioisotopeN/A1 trial
Active Trials
NCT05037799Active Not Recruiting48Est. Dec 2026
Boston Scientific
Boston ScientificCA - Valencia
1 program
SYNERGY 48 mmN/A1 trial
Active Trials
NCT03401216Unknown80Est. Apr 2019
Cordis
CordisFL - Miami Lakes
1 program
kissing balloon inflationN/A
Philips
PhilipsNetherlands - Amsterdam
1 program
roadmapN/A1 trial
Active Trials
NCT05682118Recruiting226Est. Nov 2026
Gilead Sciences
Gilead SciencesFOSTER CITY, CA
1 program
GS-6615PHASE_11 trial
Active Trials
NCT01847391Completed36Est. Nov 2013
Rhythm Pharmaceuticals
1 program
StentPHASE_41 trial
Active Trials
NCT00476957Completed8,709Est. Jul 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
AstellasRegadenoson
MedinolCatheterization, stent deployment
Rhythm PharmaceuticalsStent
PfizerEplerenone
Pfizercelecoxib
MedtronicResolute Integrity™ Zotarolimus-Eluting Coronary Stent System
Innovation PharmaceuticalsStandard Western medicine treatment + Chaigui Longmu Ejiao Paste
HelixmithStage 1-Low dose VM202RY
Cook MyoSiteAMDC
HelixmithVM202-0.5 mg
Fortis TherapeuticsPassive Leg Raising
Gilead SciencesGS-6615
AstellasRegadenoson
AbbottAngiographic Guided PCI
Philipsroadmap

Showing 15 of 35 trials with date data

Clinical Trials (35)

Total enrollment: 20,190 patients across 35 trials

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

Start: Jan 2013Est. completion: Jun 201516 patients
Phase 4Completed
NCT00840775MedinolCatheterization, stent deployment

PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

Start: Apr 2009Est. completion: Jun 2011278 patients
Phase 4Completed

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)

Start: Jun 2007Est. completion: Jul 20148,709 patients
Phase 4Completed

EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia

Start: Aug 2004Est. completion: Dec 201170 patients
Phase 4Completed

Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin

Start: Apr 2003Est. completion: Apr 200524 patients
Phase 4Completed
NCT02452736MedtronicResolute Integrity™ Zotarolimus-Eluting Coronary Stent System

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Start: May 2015Est. completion: Dec 2015205 patients
Phase 3Completed
NCT07478328Innovation PharmaceuticalsStandard Western medicine treatment + Chaigui Longmu Ejiao Paste

Chaigui Longmu Ejiao Paste for Ischemic Heart Disease

Start: Mar 2026Est. completion: Dec 202860 patients
Phase 2Not Yet Recruiting
NCT03404024HelixmithStage 1-Low dose VM202RY

Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea

Start: Jan 2018Est. completion: Aug 20190
Phase 2Withdrawn

Autologous Cell Therapy for Ischemic Heart Failure

Start: Feb 2011Est. completion: Jun 20149 patients
Phase 1/2Terminated

Safety Study of Gene Therapy for Ischemic Heart Disease in Korea

Start: Jan 2007Est. completion: Aug 20149 patients
Phase 1/2Completed

Can Changes in Velocity Time Integral Serve as a Sensitive Indicator for Monitoring Changes in Stroke Volume ?

Start: Dec 201450 patients
Phase 1Unknown

A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects

Start: May 2013Est. completion: Nov 201336 patients
Phase 1Completed

Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson

Start: Jun 2009Est. completion: Dec 201150 patients
Phase 1Completed
NCT07422688AbbottAngiographic Guided PCI

Optical Coherence Tomography in Acute Vessel Evaluation

Start: Nov 2025Est. completion: Sep 20393,000 patients
N/AEnrolling By Invitation

Impact of Dynamic CoROnary RoADmap System for Guidance of Instantaneous Wave-Free Ratio or Fractional Flow Reserve

Start: Jul 2023Est. completion: Nov 2026226 patients
N/ARecruiting

Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease

Start: Jul 2022Est. completion: Dec 202648 patients
N/AActive Not Recruiting
NCT03600961BiotronikOrsiro Sirolimus Eluting Coronary Stent System

BIOFLOW-SV Portugal Registry

Start: Jul 2018Est. completion: Dec 2021173 patients
N/ATerminated
NCT03466151MedtronicResolute Onyx™ Zotarolimus-Eluting Coronary Stent System

RESOLUTE ONYX China RCT Study

Start: Apr 2018Est. completion: Jul 2026550 patients
N/AActive Not Recruiting
NCT03471845MedtronicResolute Onyx™ Zotarolimus-Eluting Coronary Stent System

RESOLUTE ONYX China Single Arm Study

Start: Mar 2018Est. completion: Aug 2026591 patients
N/AActive Not Recruiting

ABSORB Post-Approval Clinical Study

Start: Aug 2017Est. completion: Jan 20210
N/AWithdrawn
NCT03118531MedtronicResolute Integrity™ Zotarolimus-Eluting Coronary Stent System

China Resolute Integrity 34/38 mm Study

Start: Apr 2017Est. completion: Apr 202340 patients
N/ACompleted

StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantation

Start: Mar 2017Est. completion: Apr 201980 patients
N/AUnknown
NCT03064360Angeles TherapeuticsLaboratory Biomarker Analysis

Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring

Start: Feb 2017Est. completion: Jan 2020200 patients
N/ACompleted
NCT03409731AbbottABSORB GT1 BVS

Absorb GT1 Japan PMS

Start: Dec 2016Est. completion: Feb 2023135 patients
N/ACompleted
NCT02986295MerilBioMimeTM Stent, Ultimaster® Stent

Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

Start: Apr 2016Est. completion: Jan 20212,000 patients
N/AUnknown
NCT02513732AbbottXIENCE Xpedition 2.25 mm stent

XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)

Start: Jul 2014Est. completion: Sep 2020100 patients
N/ACompleted
NCT02513719AbbottXIENCE PRIME SV Everolimus Eluting Coronary Stent

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Start: May 2013Est. completion: Sep 2019312 patients
N/ACompleted
NCT01334268MedtronicTaxus Liberte Paclitaxel-Eluting Coronary Stent System

RESOLUTE China RCT

Start: Sep 2011Est. completion: Jun 2017400 patients
N/ACompleted
NCT01243749MedtronicRESOLUTE China Registry:

RESOLUTE China Registry:

Start: Dec 2010Est. completion: Dec 20171,800 patients
N/ACompleted
NCT01186198AbbottMINI TREK RX 1.20 mm Coronary Dilatation Catheter

A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions

Start: Aug 2010Est. completion: Dec 201071 patients
N/ACompleted
NCT01266239Abbottkissing balloon inflation

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

Start: Jul 2010Est. completion: Jul 2015300 patients
N/AUnknown
NCT01132456MedtronicDrug eluting stent treatment

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

Start: Jun 2010Est. completion: Apr 2016312 patients
N/ACompleted
NCT00949000AbbottICD Implantation

AnalyST Treadmill Study

Start: Jul 2009Est. completion: Feb 201150 patients
N/ACompleted
NCT00922337InspireMDMGuard Coronary Stent system

The Israeli MGuard Registry

Start: Jul 2009Est. completion: Dec 201386 patients
N/ACompleted
NCT00907855AstellasUsing Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests

Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests

Start: Apr 2009200 patients
N/ACompleted

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 20,190 patients
23 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.